LENZ Therapeutics, Inc. (LENZ) Reports Q4 Loss, Misses Revenue Estimates

LENZ Therapeutics, Inc. (LENZ) came out with a quarterly loss of $1.16 per share versus the Zacks Consensus Estimate of a loss of $0.91. This compares to a loss of $0.46 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -28.18%. A quarter ago, it was expected that this company would post a loss of $0.67 per share when it actually produced a loss of $0.59, delivering a surprise of +11.94%.Over the last four quarters, the company ...